4.4 Article

Depression in bipolar disorder versus major depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions

期刊

BIPOLAR DISORDERS
卷 14, 期 3, 页码 271-282

出版社

WILEY
DOI: 10.1111/j.1399-5618.2012.01009.x

关键词

bipolar disorder; clinical classifications; depression; epidemiology

资金

  1. National Institute on Alcohol Abuse and Alcoholism (NIAAA)
  2. NIAAA, National Institutes of Health (NIH)
  3. NIH [DA019606, DA020783, DA023200, MH076051, R01AA08159, R01DA018652, K05AA00161, MH 57910, MH 62185]
  4. Alicia Koplowitz Foundation
  5. American Foundation for Suicide Prevention
  6. New York State Psychiatric Institute
  7. CIBER de Salud Mental, Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III [CIBER07/09, CIBERSAM]
  8. Fundacion Alicia Koplowitz
  9. Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM)
  10. AstraZeneca
  11. Bristol-Myers Squibb
  12. Caja Navarra
  13. Comunidad de Madrid
  14. Fundacion Mutua Madrilena
  15. Instituto de Salud Carlos III
  16. CIBERSAM
  17. NARSAD
  18. Spanish Ministry of Education
  19. Spanish Ministry of Science and Innovation
  20. Spanish Ministry of Health
  21. Stanley Foundation
  22. Eli Lilly Co
  23. Janssen
  24. Almirall
  25. European 7th Framework Program
  26. GlaxoSmithKline
  27. Janssen-Cilag
  28. Novartis
  29. Organon
  30. Otsuka
  31. Pfizer
  32. Sanofi-aventis
  33. Seny Foundation
  34. Servier
  35. Spanish Ministry of Health, the Spanish Ministry of Science and Innovation (CIBERSAM)
  36. Stanley Medical Research Institute

向作者/读者索取更多资源

Moreno C, Hasin DS, Arango C, Oquendo MA, Vieta E, Liu S, Grant BF, Blanco C. Depression in bipolar disorder versus major depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Bipolar Disord 2012: 14: 271282. (C) 2012 The Authors. Journal compilation (C) 2012 John Wiley & Sons A/S. Objectives: To compare the clinical features and course of major depressive episodes (MDEs) occurring in subjects with bipolar I disorder (BD-I), bipolar II disorder (BD-II), and major depressive disorder (MDD). Methods: Data were drawn from the National Epidemiologic Survey on Alcohol and Related Conditions (2001-2002), a nationally representative face-to-face survey of more than 43000 adults in the USA, including 5695 subjects with lifetime MDD, 935 with BD-I and lifetime MDE, and 494 with BD-II and lifetime MDE. Differences on sociodemographic characteristics and clinical features, course, and treatment patterns of MDE were analyzed. Results: Most depressive symptoms, family psychiatric history, anxiety disorders, alcohol and drug use disorders, and personality disorders were more frequentand number of depressive symptoms per MDE was higheramong subjects with BD-I, followed by BD-II, and MDD. BD-I individuals experienced a higher number of lifetime MDEs, had a poorer quality of life, and received significantly more treatment for MDE than BD-II and MDD subjects. Individuals with BD-I and BD-II experienced their first mood episode about ten years earlier than those with MDD (21.2, 20.5, and 30.4 years, respectively). Conclusions: Our results support the existence of a spectrum of severity of MDE, with highest severity for BD-I, followed by BD-II and MDD, suggesting the utility of dimensional assessments in current categorical classifications.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据